Drugs / F-choline
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04999215 | Aug 2022 → Jul 2032 expected | — | University of Montreal Hospital Centre (CHUM) | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | F-choline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04999215 ↗ |
| Modality | Diagnostic / imaging agent | “18-F-fluorocholine (F-choline) and 11-C-choline (C-choline) are diagnostic positron emission tomography (PET) radiotracers” NCT04999215 ↗ |
| Route | Intravenous | “F-choline intravenous injection” NCT04999215 ↗ |